Catalyst
Slingshot members are tracking this event:
Keryx Biopharmaceuticals' (KERX) Auryxia in treating Iron deficiency anemia in non-dialysis dependent CKD patients PDUFA date expected November 6, 2017.
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| KERX | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 07, 2017
Occurred Source:
http://investors.keryx.com/phoenix.zhtml?c=122201&p=irol-newsArticle&ID=2314886
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Auryxia, Iron Deficiency Anemia, Chronic Kidney Disease
